Literature DB >> 8172135

Mucin and colorectal cancer metastasis.

Y Niv1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172135

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Particularly interesting new cysteine-histidine rich protein expression in colorectal adenocarcinomas.

Authors:  Zeng-Ren Zhao; Zhi-Yong Zhang; Dong-Sheng Cui; Li Jiang; Hui-Jun Zhang; Ming-Wei Wang; Xiao-Feng Sun
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

2.  Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients.

Authors:  Tao Fu; Yanliang Liu; Kai Li; Weiwei Wan; Emmanouil P Pappou; Christine A Iacobuzio-Donahue; Zachary Kerner; Stephen B Baylin; Christopher L Wolfgang; Nita Ahuja
Journal:  Oncotarget       Date:  2016-12-27

3.  From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report.

Authors:  Karolina Vernmark; Maria Albertsson; Bergthor Björnsson; Thomas Gasslander; Per Sandström; Xiao-Feng Sun; Annika Holmqvist
Journal:  BMC Cancer       Date:  2015-11-10       Impact factor: 4.430

4.  IRF1 inhibits the proliferation and metastasis of colorectal cancer by suppressing the RAS-RAC1 pathway.

Authors:  Min Hong; Zuoyang Zhang; Qing Chen; Yanxia Lu; Jianming Zhang; Chun Lin; Fan Zhang; Wenjuan Zhang; Xiaomin Li; Wei Zhang; Xuenong Li
Journal:  Cancer Manag Res       Date:  2018-12-31       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.